Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin‐Homing T Cells of Atopic Dermatitis Patients
Clinical & Experimental Allergy · 2026-11 · 56 (11) · 1452-1455
DOI: 10.1111/cea.70397 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical & Experimental Allergy, online erschienen am 15.07.2026. Verfasst von Ahmed M I Elfiky und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Health~Holland, the Top Sector Life Sciences & Health.
Abstract (Originalsprache)
Skin‐homing T‐helper cells show a unique DNA methylome in AD. Dupilumab partially corrects, whereas upadacitinib broadens methylation differences and reinforces AD‐related methylation signatures.
Autor:innen und Institutionen
- Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
- Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
- Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
ORCID-Profile: Ahmed M I Elfiky, Hidde M Smits, Coco Dekkers, Celeste M Boesjes, Julia Drylewicz, Marjolein de Bruin-Weller
Förderung
- Health~Holland, the Top Sector Life Sciences & Health
Zitieren
APA
Elfiky, A. M. I., Smits, H. M., van der Wal, M., Dekkers, C., Boesjes, C. M., Drylewicz, J., de Bruin-Weller, M., & van Wijk, F. (2026). Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin‐Homing T Cells of Atopic Dermatitis Patients. Clinical & Experimental Allergy, 56(11), 1452-1455. https://doi.org/10.1111/cea.70397
Vancouver
Elfiky AMI, Smits HM, van der Wal M, Dekkers C, Boesjes CM, Drylewicz J, et al. Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin‐Homing T Cells of Atopic Dermatitis Patients. Clinical & Experimental Allergy. 2026;56(11):1452-1455. doi:10.1111/cea.70397
BibTeX
@article{Elfiky2026,
author = {Elfiky, Ahmed M I and Smits, Hidde M and van der Wal, Marlot and Dekkers, Coco and Boesjes, Celeste M and Drylewicz, Julia and de Bruin-Weller, Marjolein and van Wijk, Femke},
title = {Impact of Dupilumab and Upadacitinib Treatment on Epigenetic and Transcriptomic Alterations in Skin‐Homing T Cells of Atopic Dermatitis Patients},
journal = {Clinical & Experimental Allergy},
year = {2026},
volume = {56},
number = {11},
pages = {1452--1455},
doi = {10.1111/cea.70397}
}
EUVIMED